Cargando…

Estimation of current and post-treatment retinal function in chronic central serous chorioretinopathy using artificial intelligence

Refined understanding of the association of retinal microstructure with current and future (post-treatment) function in chronic central serous chorioretinopathy (cCSC) may help to identify patients that would benefit most from treatment. In this post-hoc analysis of data from the prospective, random...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pfau, Maximilian, van Dijk, Elon H. C., van Rijssen, Thomas J., Schmitz-Valckenberg, Steffen, Holz, Frank G., Fleckenstein, Monika, Boon, Camiel J. F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516921/ https://www.ncbi.nlm.nih.gov/pubmed/34650220 http://dx.doi.org/10.1038/s41598-021-99977-4

Ejemplares similares

Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy
por: van Rijssen, Thomas J., et al.
Publicado: (2018)

Central serous chorioretinopathy in active endogenous Cushing’s syndrome
por: Brinks, Joost, et al.
Publicado: (2021)

Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea
por: van Dijk, Elon H. C., et al.
Publicado: (2017)

Clinical characteristics and long-term visual outcome of severe phenotypes of chronic central serous chorioretinopathy
por: Mohabati, Danial, et al.
Publicado: (2018)

Sex Hormones in Males and Females with Active Central Serous Chorioretinopathy
por: Brinks, Joost, et al.
Publicado: (2023)

Central serous chorioretinopathy in primary hyperaldosteronism
por: van Dijk, Elon H. C., et al.
Publicado: (2016)

Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy
por: van Rijssen, Thomas J., et al.
Publicado: (2020)

Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy
por: Mohabati, Danial, et al.
Publicado: (2018)

Systemic complement activation in central serous chorioretinopathy
por: van Dijk, Elon H. C., et al.
Publicado: (2017)

Re: Trivizki et al. Local Geographic Atrophy Growth Rates Not Influenced by Close Proximity to Non-Exudative Type 1 Macular Neovascularization
por: Pfau, Maximilian, et al.
Publicado: (2022)

Prospective evaluation of changes in choroidal vascularity index after half-dose photodynamic therapy versus micropulse laser treatment in chronic central serous chorioretinopathy
por: van Rijssen, Thomas J., et al.
Publicado: (2020)

Correlation between redefined optical coherence tomography parameters and best-corrected visual acuity in non-resolving central serous chorioretinopathy treated with half-dose photodynamic therapy
por: van Rijssen, Thomas J., et al.
Publicado: (2018)

Subretinal fluid morphology in chronic central serous chorioretinopathy and its relationship to treatment: a retrospective analysis on PLACE trial data
por: Subhi, Yousif, et al.
Publicado: (2021)

Stress and vision-related quality of life in acute and chronic central serous chorioretinopathy
por: Kumar, Meenakshi, et al.
Publicado: (2020)

Artificial intelligence for morphology-based function prediction in neovascular age-related macular degeneration
por: von der Emde, Leon, et al.
Publicado: (2019)

Fundus autofluorescence abnormalities can predict fluorescein angiography abnormalities in patients with chronic central serous chorioretinopathy
por: Mohabati, Danial, et al.
Publicado: (2023)

Choroidal arteriovenous anastomoses: a hypothesis for the pathogenesis of central serous chorioretinopathy and other pachychoroid disease spectrum abnormalities
por: Brinks, Joost, et al.
Publicado: (2022)

Evaluation of Choroidal Layer Thickness in Central Serous Chorioretinopathy
por: Hanumunthadu, Daren, et al.
Publicado: (2019)

Exome sequencing in families with chronic central serous chorioretinopathy
por: Schellevis, Rosa L., et al.
Publicado: (2019)

Cushing’s Syndrome and Hypothalamic–Pituitary–Adrenal Axis Hyperactivity in Chronic Central Serous Chorioretinopathy
por: van Haalen, Femke M., et al.
Publicado: (2018)

SINGLE-SESSION BILATERAL REDUCED-SETTINGS PHOTODYNAMIC THERAPY FOR BILATERAL CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
por: Pauleikhoff, Laurenz J.B., et al.
Publicado: (2023)

INCREASING EVIDENCE FOR THE SAFETY OF FOVEA-INVOLVING HALF-DOSE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
por: Feenstra, Helena M. A., et al.
Publicado: (2023)

GENETIC RISK FACTORS IN SEVERE, NONSEVERE AND ACUTE PHENOTYPES OF CENTRAL SEROUS CHORIORETINOPATHY
por: Mohabati, Danial, et al.
Publicado: (2020)

Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3
por: Feenstra, Helena M. A., et al.
Publicado: (2022)

Long‐term follow‐up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser
por: van Rijssen, Thomas J., et al.
Publicado: (2021)

Evaluation of Two Systems for Fundus-Controlled Scotopic and Mesopic Perimetry in Eye with Age-Related Macular Degeneration
por: Steinberg, Julia S., et al.
Publicado: (2017)

Association of complement C3 inhibitor pegcetacoplan with reduced photoreceptor degeneration beyond areas of geographic atrophy
por: Pfau, Maximilian, et al.
Publicado: (2022)

Central serous chorioretinopathy: Pathophysiology, systemic associations, and a novel etiological classification
por: Jain, Manish, et al.
Publicado: (2022)

Response to Letter to the Editor From Behar-Cohen et al.: The Cortisol Response of Male and Female Choroidal Endothelial Cells: Implications for Central Serous Chorioretinopathy
por: Brinks, Joost, et al.
Publicado: (2021)

The Cortisol Response of Male and Female Choroidal Endothelial Cells: Implications for Central Serous Chorioretinopathy
por: Brinks, Joost, et al.
Publicado: (2021)

Risk of Recurrence and Transition to Chronic Disease in Acute Central Serous Chorioretinopathy
por: Mohabati, Danial, et al.
Publicado: (2020)

Longitudinal Analysis of Structural and Functional Changes in Presence of Reticular Pseudodrusen Associated With Age-Related Macular Degeneration
por: Sassmannshausen, Marlene, et al.
Publicado: (2020)

Prognostic value of intermediate age-related macular degeneration phenotypes for geographic atrophy progression
por: Thiele, Sarah, et al.
Publicado: (2021)

Management of central serous chorioretinopathy: Expert panel discussion
por: Chhablani, Jay, et al.
Publicado: (2018)

Mesopic and Dark-Adapted Two-Color Fundus-Controlled Perimetry in Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
por: von der Emde, Leon, et al.
Publicado: (2018)

Modeling of atrophy size trajectories: variable transformation, prediction and age-of-onset estimation
por: Behning, Charlotte, et al.
Publicado: (2021)

Photodynamic Therapy for Chorioretinal Diseases: A Practical Approach
por: van Dijk, Elon H. C., et al.
Publicado: (2020)

Exome sequencing in patients with chronic central serous chorioretinopathy
por: Schellevis, Rosa L., et al.
Publicado: (2019)

Scientific Literature Database Coverage of Randomized Clinical Trials for Central Serous Chorioretinopathy
por: Boberg-Ans, Lars C., et al.
Publicado: (2023)

CLINICAL CHARACTERISTICS AND OUTCOME OF POSTERIOR CYSTOID MACULAR DEGENERATION IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
por: Mohabati, Danial, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_njgge5j9ngmcm12fhq36m8to95